| ADM | Acinar-Ductal Metaplasia |
| αKG | α-ketoglutarate |
| AKT | Protein Kinase B |
| apCAFs | Antigen-Presenting Cancer-Associated Macrophages |
| APCs | Antigen-Presenting Cells |
| ARID1A | AT-rich interactive domain-containing protein 1A |
| α-SMA | α-Smooth Muscle Actin |
| BM | Bone Marrow |
| B-reg | Regulatory B Lymphocytes |
| C1Q | complement component 1q |
| CAFs | Cancer-Associated Fibroblasts |
| CAR-T | chimeric antigen receptor T-cell therapy |
| CAR-M | chimeric antigen receptor macrophages therapy |
| CARTmeso cells | Mesothelin-directed CAR-T cells |
| CCL2 | C-C Chemokine Ligand |
| CD | Cluster of Differentiation |
| CD133 | Prominin1 |
| CDKN2A | cyclin-dependent kinase inhibitor 2A |
| CEA | Carcinoembryonic Antigen |
| CEACAM | CEA-related cell adhesion molecule |
| CICs | Cancer Inducing Cells |
| Col1a1 | Collagen, type I, alpha 1 |
| Co-SMAD | co-mediator SMAD |
| csCAFs | Complement-Secreting Cancer-Associated Macrophages |
| CTLs | Cytotoxic T Lymphocytes |
| CXCL | C-X-C motif Chemokine ligand |
| DCs | Dendritic Cells |
| ECM | Extracellular Matrix |
| EMT | Epithelial-Mesenchymal Transition |
| ERK | Extracellular signal-regulated kinase |
| EVs | Extracellular Vesicles |
| FAP | Fibroblast Activation Protein |
| FGF | Fibroblasts Growth Factor |
| FOXP3 | Forkhead box P3 |
| FSP-1 | Fibroblast Surface Protein 1 |
| GAGs | glycosaminoglycans |
| GM-CSF | Granulocyte-Macrophage Colony Stimulating Factor |
| GREM1 | Gremlin 1 |
| HRAS | Harvey rat sarcoma viral |
| HLA | Human Leukocyte Antigen |
| HLA-DR | Human Leukocyte Antigen-DR isotype |
| iCAFs | Inflammatory Cancer-Associated Fibroblasts |
| IHH | Indian Hedgehog |
| IL | Interleukin |
| IPMN | intraductal papillary mucinous neoplasm |
| KRAS | Kirsten Rat Sarcoma Virus |
| M-CSF | Macrophage-Colony Stimulating Factor |
| MAGUK | Membrane-Associated Guanylate Kinase |
| MCL-1 | myeloid cell leukemia-1 |
| MDSCs | Myeloid-Derived Suppressor Cells |
| MHC | Major Histocompatibility Complex |
| MIF | Macrophage Migration Inhibiting Factor |
| MMPs | Matrix Metalloproteinases |
| MMR | Mismatch Repair |
| MPP6 | MAGUK P55 Subfamily Member |
| MSCs | Mesenchymal Stem Cells |
| MVBs | Multivesicular Bodies |
| MYC | myelocytomatosis oncogene |
| myCAFs | Myofibroblastic Cancer-Associated Macrophages |
| NETs | Neutrophil Extracellular Traps |
| NRAS | (Neuroblasoma rat sarcoma viral |
| NK | Natural Killer |
| NLRP3 | NLR family pyrin domain containing 3 |
| Onf-FN | oncofetal Fibronectin |
| PanIN | Pancreatic Intraepithelial Neoplasia |
| PB | Peripheral Blood |
| PC | Pancreatic Cancer |
| PCCs | Pancreatic Cancer Cells |
| PDAC | Pancreatic Ductal Adenocarcinoma |
| PDGFR | Platelet-derived growth factor receptor |
| PD-L1 | Programmed death-ligand 1 |
| PI3K | phosphatidylinositol-3 kinase |
| pp-GalNAc-T6 | UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-6 |
| PSCs | Pancreatic Stellate Cells |
| RAF | rapidly accelerated fibrosarcoma |
| RANTES | Regulated on Activation, Normal T Cell Expressed and Secreted |
| R-SMAD | receptor-regulated SMAD |
| R0 | resections: no cancer cells present microscopically at the primary tumor site |
| ROS | Reactive Oxygen Species |
| Saa3 | Serum Amyloid A 3 |
| SBE | SMAD Binding Element |
| SHH | Sonic Hedgehog |
| SMAD | Small Mother Against Decapentaplegic |
| TAMs | Tumour-Associated Macrophages |
| TCA | Tricarboxylic Acid |
| TET | ten-eleven translocation methylcytosine dioxygenases |
| TEXs | Tumor-Derived Exosomes |
| TGF-β | Transforming Growth Factor β |
| TGFβR | Transforming Growth Factor β Receptor |
| TLR | Toll-Like Receptor |
| TME | Tumour Microenvironment |
| TNF-α | Tumor Necrosis Factor alpha |
| TP53 | Tumour Protein 53 |
| T-reg | Regulatory T Lymphocytes |
| VEGF | Vascular Endothelial Growth Factor |
| YAP | Yes-associated protein |